inserting ‘‘Amounts appropriated to carry out 
this section may be used for’’; 
(39) by striking section 468; 
(40) in section 481A— 
(A) in the matter preceding subparagraph 
(A) of subsection (c)(2)— 
(i) by striking the term ‘‘under sub-
section (i)(1)’’ and inserting ‘‘to carry out 
this section’’; and 
(ii) by striking ‘‘under such sub-
section’’ and inserting ‘‘to carry out this 
section’’; and 
(B) by striking subsection (i); 
(41) in subsection (a) of section 481B, by strik-
ing ‘‘under section 481A(h)’’ and inserting ‘‘to carry 
out section 481A’’; 
(42) by striking subsection (c) in the section 
481C that relates to general clinical research cen-
ters; 
(43) by striking subsection (e) in section 485C; 
(44) by striking subsection (l) in section 485E; 
(45) by striking subsection (h) in section 485F; 
(46) by striking subsection (e) in section 485G; 
(47) by striking subsection (d) of section 487; 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
(48) by striking subsection (c) of section 487A; 
and 
(49) by striking subsection (c) in the section 
487F that relates to a loan repayment program re-
garding clinical researchers. 
(c) RULE OF CONSTRUCTION REGARDING CONTINU-
ATION OF PROGRAMS.—The amendment of a program by 
a provision of subsection (b) may not be construed as ter-
minating the authority of the Federal agency involved to 
carry out the program. 
SEC. 5. REPORTS. 
(a) REPORT OF DIRECTOR OF NIH.—The Public 
Health Service Act (42 U.S.C. 201 et seq.), as amended 
by section 4(a) of this Act, is amended— 
(1) by redesignating section 403A as section 
403C; 
(2) in section 1710(a), by striking ‘‘section 
403A’’ and inserting ‘‘section 403C’’; and 
(3) by striking section 403 and inserting the 
following sections: 
‘‘SEC. 402B. ELECTRONIC CODING OF GRANTS AND ACTIVI-
TIES. 
‘‘The Secretary, acting through the Director of NIH, 
shall establish an electronic system to uniformly code re-
search grants and activities of the Office of the Director 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
and of all the national research institutes and national 
centers. The electronic system shall be searchable by a va-
riety of codes, such as the type of research grant, the re-
search entity managing the grant, and the public health 
area of interest. When permissible, the Secretary, acting 
through the Director of NIH, shall provide information 
on relevant literature and patents that are associated with 
research activities of the National Institutes of Health. 
‘‘SEC. 403. BIENNIAL REPORTS OF DIRECTOR OF NIH. 
‘‘(a) IN GENERAL.—The Director of NIH shall sub-
mit directly to the Congress on a biennial basis a report 
in accordance with this section. The first report shall be 
submitted not later than 1 year after the date of the enact-
ment of the National Institutes of Health Reform Act of 
2006. Each such report shall include the following infor-
mation: 
‘‘(1) An assessment of the state of biomedical 
and behavioral research. 
‘‘(2) A description of the activities conducted or 
supported by the agencies of the National Institutes 
of Health and policies respecting the programs of 
such agencies. 
‘‘(3) Classification and justification for the pri-
orities established by the agencies, including a stra-
tegic plan and recommendations for future research 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
initiatives to be carried out under section 402(b)(7) 
through the Division of Program Coordination, 
Planning, and Strategic Initiatives. 
‘‘(4) A catalog of all the research activities of 
the agencies, prepared in accordance with the fol-
lowing: 
‘‘(A) The catalog shall, for each such activ-
ity— 
‘‘(i) identify the agency or agencies in-
volved; 
‘‘(ii) state whether the activity was 
carried out directly by the agencies or was 
supported by the agencies and describe to 
what extent the agency was involved; and 
‘‘(iii) identify whether the activity was 
carried out through a center of excellence. 
‘‘(B) In the case of clinical research, the 
catalog shall, as appropriate, identify study 
populations by demographic variables and other 
variables that contribute to research on health 
disparities. 
‘‘(C) Research activities listed in the cata-
log shall include the following: 
‘‘(i) Epidemiological studies and longi-
tudinal studies. 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
‘‘(ii) Disease registries, information 
clearinghouses, and other data systems. 
‘‘(iii) Public education and informa-
tion campaigns. 
‘‘(iv) Training activities, including 
National Research Service Awards and a 
breakdown by demographic variables and 
other appropriate categories. 
‘‘(v) Clinical trials, including a break-
down of participation by study populations 
and demographic variables and such other 
information as may be necessary to dem-
onstrate compliance with section 492B (re-
garding inclusion of women and minorities 
in clinical research). 
‘‘(vi) Translational research activities 
with other agencies of the Public Health 
Service. 
‘‘(5) A summary of the research activities 
throughout the agencies, which summary shall be or-
ganized by the following categories: 
‘‘(A) Cancer. 
‘‘(B) Neurosciences. 
‘‘(C) Life stages, human development, and 
rehabilitation. 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
‘‘(D) Organ systems. 
‘‘(E) Autoimmune diseases. 
‘‘(F) Genomics. 
‘‘(G) Molecular biology and basic science. 
‘‘(H) Technology development. 
‘‘(I) Chronic diseases, including pain and 
palliative care. 
‘‘(J) Infectious diseases and bioterrorism. 
‘‘(K) Health disparities. 
‘‘(L) Such additional categories as the Di-
rector determines to be appropriate. 
‘‘(b) REQUIREMENT REGARDING DISEASE-SPECIFIC 
RESEARCH ACTIVITIES.—In a report under subsection 
(a), the Director of NIH, when reporting on research ac-
tivities relating to a specific disease, disorder, or other ad-
verse health condition, shall— 
‘‘(1) present information in a standardized for-
mat; 
‘‘(2) identify the actual dollar amounts obli-
gated for such activities; and 
‘‘(3) include a plan for research on the specific 
disease, disorder, or other adverse health condition, 
including a statement of objectives regarding the re-
search, the means for achieving the objectives, a 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
date by which the objectives are expected to be 
achieved, and justifications for revisions to the plan. 
‘‘(c) ADDITIONAL REPORTS.—In addition to reports 
required by subsections (a) and (b), the Director of NIH 
may submit to the Congress such additional reports as the 
Director determines to be appropriate. 
‘‘SEC. 403A. ANNUAL REPORTING TO INCREASE INTER-
AGENCY COLLABORATION AND COORDINA-
TION. 
‘‘(a) COLLABORATION WITH OTHER HHS AGEN-
CIES.—On an annual basis, the Director of NIH shall sub-
mit to the Secretary a report on the activities of the Na-
tional Institutes of Health involving collaboration with 
other agencies of the Department of Health and Human 
Services. 
‘‘(b) CLINICAL TRIALS.—Each calendar year, the Di-
rector of NIH shall submit to the Commissioner of Food 
and Drugs a report that identifies each clinical trial that 
is registered during such calendar year in the databank 
of information established under section 402(j). 
‘‘(c) HUMAN TISSUE SAMPLES.—On an annual basis, 
the Director of NIH shall submit to the Congress a report 
that describes how the National Institutes of Health and 
its agencies store and track human tissue samples. 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
‘‘(d) FIRST REPORT.—The first report under sub-
sections (a), (b), and (c) shall be submitted not later than 
1 year after the date of the enactment of the National 
Institutes of Health Reform Act of 2006. 
‘‘SEC. 403B. ANNUAL REPORTING TO PREVENT FRAUD AND 
ABUSE. 
‘‘(a) WHISTLEBLOWER COMPLAINTS.— 
‘‘(1) IN GENERAL.—On an annual basis, the 
Director of NIH shall submit to the Inspector Gen-
eral of the Department of Health and Human Serv-
ices, the Secretary, the Committee on Energy and 
Commerce of the House of Representatives, and the 
Committee on Health, Education, Labor, and Pen-
sions of the Senate a report summarizing the activi-
ties of the National Institutes of Health relating to 
whistleblower complaints. 
‘‘(2) CONTENTS.—For each whistleblower com-
plaint pending during the year for which a report is 
submitted under this subsection, the report shall 
identify the following: 
‘‘(A) Each agency of the National Insti-
tutes of Health involved. 
‘‘(B) The status of the complaint. 
‘‘(C) The resolution of the complaint to 
date. 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
‘‘(b) EXPERTS AND CONSULTANTS.—On an annual 
basis, the Director of NIH shall submit to the Inspector 
General of the Department of Health and Human Serv-
ices, the Secretary, the Committee on Energy and Com-
merce of the House of Representatives, and the Committee 
on Health, Education, Labor, and Pensions of the Senate 
a report that— 
‘‘(1) identifies the number of experts and con-
sultants, including any special consultants, whose 
services are obtained by the National Institutes of 
Health or its agencies; 
‘‘(2) specifies whether such services were ob-
tained under section 207(f), section 402(d), or other 
authority; 
‘‘(3) describes the qualifications of such experts 
and consultants; 
‘‘(4) describes the need for hiring such experts 
and consultants; and 
‘‘(5) if such experts and consultants make fi-
nancial disclosures to the National Institutes of 
Health or any of its agencies, specifies the income, 
gifts, assets, and liabilities so disclosed. 
‘‘(c) FIRST REPORT.—The first report under sub-
sections (a) and (b) shall be submitted not later than 1 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS
year after the date of the enactment of the National Insti-
tutes of Health Reform Act of 2006.’’. 
(b) STRIKING
OF OTHER REPORTING REQUIRE-
MENTS FOR NIH.— 
(1) PUBLIC HEALTH SERVICE ACT; TITLE IV.— 
Title IV of the Public Health Service Act, as amend-
ed by section 4(b) of this Act, is amended— 
(A) in section 404E(b)— 
(i) by amending paragraph (3) to read 
as follows: 
‘‘(3) COORDINATION OF CENTERS.—The Direc-
tor of NIH shall, as appropriate, provide for the co-
ordination of information among centers under para-
graph (1) and ensure regular communication be-
tween such centers.’’; and 
(ii) by striking subsection (f) and re-
designating subsection (g) as subsection 
(f); 
(B) in section 404F(b)(1), by striking sub-
paragraphs (F) and (G); 
(C) by striking section 407; 
(D) in section 409C(b), by striking para-
graph (4) and redesignating paragraphs (5) and 
(6) as paragraphs (4) and (5), respectively; 
VerDate Aug 31 2005 
03:19 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00047
Fmt 6652
Sfmt 6201
E:\BILLS\H6164.IH
H6164
jcorcoran on PRODPC62 with BILLS